Clinical trial
The TearAD Study: Tear Biomarkers for Alzheimer's Disease (AD) Screening and Diagnosis
NCT05655793 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The TearAD Study: Tear Biomarkers for Alzheimer's Disease (AD) Screening and Diagnosis
- Lead sponsor
- Maastricht University Medical Center
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 9, 2022
- Completion date
- July 1, 2025
- Enrollment
- 200 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.